Related references
Note: Only part of the references are listed.The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
Zobair M. Younossi et al.
HEPATOLOGY (2023)
Resistance to thyroid hormone induced tachycardia in RTHα syndrome
Riccardo Dore et al.
Nature Communications (2023)
Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis
Jin Zhou et al.
THYROID (2022)
Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196
Georg Sebastian Hoenes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis
Eva K. Wirth et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2022)
Holistic characterization of single-hepatocyte transcriptome responses to high-fat diet
Sung Rye Park et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD
Andrea Caddeo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Dyslipidemia, Insulin Resistance, Ectopic Lipid Accumulation, and Vascular Function in Resistance to Thyroid Hormone β
Carla Moran et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
Eveline Bruinstroop et al.
MOLECULAR METABOLISM (2021)
Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication
Anne Loft et al.
CELL METABOLISM (2021)
Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH
Stephen A. Harrison et al.
HEPATOLOGY COMMUNICATIONS (2021)
Thyroid Hormone Analogues: An Update
Riccardo Zucchi
THYROID (2020)
Thyroid hormone receptor α in skeletal muscle is essential for T3-mediated increase in energy expenditure
Trine S. Nicolaisen et al.
FASEB JOURNAL (2020)
Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease
David H. Ipsen et al.
ADVANCES IN NUTRITION (2020)
Maternal Brown Fat Thermogenesis Programs Glucose Tolerance in the Male Offspring
Rebecca Oelkrug et al.
CELL REPORTS (2020)
The answer to the question What is the best housing temperature to translate mouse experiments to humans? is: thermoneutrality
Alexander W. Fischer et al.
MOLECULAR METABOLISM (2019)
Thyroid-Hormone-Induced Browning of White Adipose Tissue Does Not Contribute to Thermogenesis and Glucose Consumption
Kornelia Johann et al.
CELL REPORTS (2019)
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2019)
Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis
Donghee Kim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD
Eveline Bruinstroop et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Direct effects of thyroid hormones on hepatic lipid metabolism
Rohit A. Sinha et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
Begona Porteiro et al.
MOLECULAR METABOLISM (2018)
Optimal housing temperatures for mice to mimic the thermal environment of humans: An experimental study
Alexander W. Fischer et al.
MOLECULAR METABOLISM (2018)
Reduced expression of thyroid hormone receptor β in human nonalcoholic steatohepatitis
Christin Krause et al.
ENDOCRINE CONNECTIONS (2018)
Role of the Bile Acid Transporter SLC10A1 in Liver Targeting of the Lipid-Lowering Thyroid Hormone Analog Eprotirome
Simone Kersseboom et al.
ENDOCRINOLOGY (2017)
Tissue thyroid hormone metabolism is differentially regulated during illness in mice
Anita Boelen et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling
Daniel A. Giles et al.
NATURE MEDICINE (2017)
Changes in Hepatic TR Protein Expression, Lipogenic Gene Expression, and Long-Chain Acylcarnitine Levels During Chronic Hyperthyroidism and Triiodothyronine Withdrawal in a Mouse Model
Kenji Ohba et al.
THYROID (2017)
Thyroid Hormone Receptor Beta in the Ventromedial Hypothalamus Is Essential for the Physiological Regulation of Food Intake and Body Weight
Saira Hameed et al.
CELL REPORTS (2017)
Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years
Ulla Ludwig et al.
BMC ENDOCRINE DISORDERS (2015)
Repair-Related Activation of Hedgehog Signaling in Stromal Cells Promotes Intrahepatic Hypothyroidism
Brittany N. Bohinc et al.
ENDOCRINOLOGY (2014)
Adipose tissues and thyroid hormones
Maria-Jesus Obregon
FRONTIERS IN PHYSIOLOGY (2014)
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
Daniel F. Vatner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
NAFLD, NASH and liver cancer
Gregory A. Michelotti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Homozygous Thyroid Hormone Receptor β-Gene Mutations in Resistance to Thyroid Hormone: Three New Cases and Review of the Literature
Alfonso Massimiliano Ferrara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Inverse Association Between Serum Free Thyroxine Levels and Hepatic Steatosis: Results from the Study of Health in Pomerania
Till Ittermann et al.
THYROID (2012)
Cardiac hypertrophy and thyroid hormone signaling
Wolfgang Dillmann
HEART FAILURE REVIEWS (2010)
Reduction of Hepatic Steatosis in Rats and Mice After Treatment with a Liver-Targeted Thyroid Hormone Receptor Agonist
Edward E. Cable et al.
HEPATOLOGY (2009)
Distinct Dysregulation of Lipid Metabolism by Unliganded Thyroid Hormone Receptor Isoforms
O. Araki et al.
MOLECULAR ENDOCRINOLOGY (2009)
Endocrine and liver interaction: the role of endocrine pathways in NASH
Paola Loria et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver
Lars P. Klieverik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality
S. J. Swoap et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Thyroid hormone (T3) and TRβ agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats
Andrea Perra et al.
FASEB JOURNAL (2008)
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
Anders Berkenstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice
L Johansson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Zonal expression of the thyroid hormone receptor a isoforms in rodent liver
B Zandieh-Doulabi et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Requirement for thyroid hormone receptor β in T3 regulation of cholesterol metabolism in mice
H Gullberg et al.
MOLECULAR ENDOCRINOLOGY (2002)
Share Paper
